195 related articles for article (PubMed ID: 32107605)
21. Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
van der Molen AJ; Reimer P; Dekkers IA; Bongartz G; Bellin MF; Bertolotto M; Clement O; Heinz-Peer G; Stacul F; Webb JAW; Thomsen HS
Eur Radiol; 2018 Jul; 28(7):2845-2855. PubMed ID: 29426991
[TBL] [Abstract][Full Text] [Related]
22. [Guideline 'Precautionary measures for contrast media containing iodine'].
van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
[TBL] [Abstract][Full Text] [Related]
23. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
Davenport MS; Perazella MA; Yee J; Dillman JR; Fine D; McDonald RJ; Rodby RA; Wang CL; Weinreb JC
Radiology; 2020 Mar; 294(3):660-668. PubMed ID: 31961246
[TBL] [Abstract][Full Text] [Related]
24. Cost of screening strategies for kidney disease before intravenous contrast administration.
Moos SI; de Weijert RS; Nagan G; Stoker J; Bipat S
Neth J Med; 2014 Jun; 72(5):271-80. PubMed ID: 24930461
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis against postcontrast acute kidney injury (PC-AKI): updates in the ESUR guidelines 10.0 and critical review.
Sebastià C; Nicolau C; Martín de Francisco ÁL; Poch E; Oleaga L
Radiologia (Engl Ed); 2020; 62(4):292-297. PubMed ID: 32029241
[TBL] [Abstract][Full Text] [Related]
26. Radiology departmental policy compliance with Swedish guidelines regarding post-contrast acute kidney injury for examinations with iodinated contrast media.
Bjällmark A; Bazzi M; Karlsson M; Krakys E; Kihlberg J
Radiography (Lond); 2021 Nov; 27(4):1058-1063. PubMed ID: 34023227
[TBL] [Abstract][Full Text] [Related]
27. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.
Brar SS; Aharonian V; Mansukhani P; Moore N; Shen AY; Jorgensen M; Dua A; Short L; Kane K
Lancet; 2014 May; 383(9931):1814-23. PubMed ID: 24856027
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
29. Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis.
Ng CS; Kalva SP; Gunnarsson C; Ryan MP; Baker ER; Mehta RL
Cancer Imaging; 2018 Aug; 18(1):30. PubMed ID: 30143056
[TBL] [Abstract][Full Text] [Related]
30. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
31. Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
Tsushima Y; Ishiguchi T; Murakami T; Hayashi H; Hayakawa K; Fukuda K; Korogi Y; Sugimoto H; Takehara Y; Narumi Y; Arai Y; Kuwatsuru R; Yoshimitsu K; Awai K; Kanematsu M; Takagi R
Jpn J Radiol; 2016 Feb; 34(2):130-9. PubMed ID: 26662468
[TBL] [Abstract][Full Text] [Related]
32. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version.
JSN, JRS and JCS Joint Working Group
Circ J; 2013; 77(7):1883-914. PubMed ID: 23803256
[No Abstract] [Full Text] [Related]
33. Temporal trends of post-contrast acute kidney injury in patients with intravenous administration of iodinated contrast medium.
Wu X; Yan P; Duan SB; Luo XQ; Zhang NY; Deng YH
Ren Fail; 2023; 45(2):2251588. PubMed ID: 37724551
[TBL] [Abstract][Full Text] [Related]
34. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
[TBL] [Abstract][Full Text] [Related]
35. [Renal toxicity of contrast agents in oncologic patients].
Amet S; Deray G
Bull Cancer; 2012 Mar; 99(3):295-307. PubMed ID: 22082610
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
Marashizadeh A; Sanati HR; Sadeghipour P; Peighambari MM; Moosavi J; Shafe O; Firouzi A; Zahedmehr A; Maadani M; Shakerian F; Kiani R; Mohebbi B; Alemzadeh-Ansari MJ; Tahvili R; Naghavi B
Int Urol Nephrol; 2019 Oct; 51(10):1815-1822. PubMed ID: 31332700
[TBL] [Abstract][Full Text] [Related]
37. Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study.
Sebastià C; Páez-Carpio A; Guillen E; Paño B; Arnaiz JA; De Francisco ALM; Nicolau C; Oleaga L
Support Care Cancer; 2022 Feb; 30(2):1879-1887. PubMed ID: 34613475
[TBL] [Abstract][Full Text] [Related]
38. Safety of a rapid outpatient hydration protocol for patients with renal impairment requiring intravenous iodinated contrast media for computed tomography.
Wee NK; Tiong SC; Lee CH; H'ng MWC
Singapore Med J; 2021 Nov; 62(11):588-593. PubMed ID: 32460449
[TBL] [Abstract][Full Text] [Related]
39. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.
Ohno I; Hayashi H; Aonuma K; Horio M; Kashihara N; Okada H; Komatsu Y; Tamura S; Awai K; Yamashita Y; Kuwatsuru R; Hirayama A; Saito Y; Murohara T; Tamaki N; Sato A; Takayama T; Imai E; Yasuda Y; Koya D; Tsubakihara Y; Horie S; Korogi Y; Narumi Y; Hayakawa K; Daida H; Node K; Kubota I;
Clin Exp Nephrol; 2013 Aug; 17(4):441-79. PubMed ID: 23896863
[No Abstract] [Full Text] [Related]
40. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.
Ohno I; Hayashi H; Aonuma K; Horio M; Kashihara N; Okada H; Komatsu Y; Tamura S; Awai K; Yamashita Y; Kuwatsuru R; Hirayama A; Saito Y; Murohara T; Tamaki N; Sato A; Takayama T; Imai E; Yasuda Y; Koya D; Tsubakihara Y; Horie S; Korogi Y; Narumi Y; Hayakawa K; Daida H; Node K; Kubota I; ; ;
Jpn J Radiol; 2013 Aug; 31(8):546-84. PubMed ID: 23884513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
